DK270289A - Oligopeptider med cycliske, prolin-analoge aminosyrer og farmaceutisk acceptable salte deraf samt deres anvendelse - Google Patents

Oligopeptider med cycliske, prolin-analoge aminosyrer og farmaceutisk acceptable salte deraf samt deres anvendelse Download PDF

Info

Publication number
DK270289A
DK270289A DK270289A DK270289A DK270289A DK 270289 A DK270289 A DK 270289A DK 270289 A DK270289 A DK 270289A DK 270289 A DK270289 A DK 270289A DK 270289 A DK270289 A DK 270289A
Authority
DK
Denmark
Prior art keywords
olycopeptides
prolin
cyclic
amino acids
acceptable salts
Prior art date
Application number
DK270289A
Other languages
Danish (da)
English (en)
Other versions
DK270289D0 (da
Inventor
Stephan Henke
Dietrich Brocks
Volkmar Guenzler-Pukall
Kari Ilkka Kivirikko
Raili Mirja Helena Myllylae
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK270289D0 publication Critical patent/DK270289D0/da
Publication of DK270289A publication Critical patent/DK270289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK270289A 1988-06-03 1989-06-02 Oligopeptider med cycliske, prolin-analoge aminosyrer og farmaceutisk acceptable salte deraf samt deres anvendelse DK270289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818850A DE3818850A1 (de) 1988-06-03 1988-06-03 Oligopeptide mit zyklischen prolin-analogen aminosaeuren

Publications (2)

Publication Number Publication Date
DK270289D0 DK270289D0 (da) 1989-06-02
DK270289A true DK270289A (da) 1989-12-04

Family

ID=6355744

Family Applications (1)

Application Number Title Priority Date Filing Date
DK270289A DK270289A (da) 1988-06-03 1989-06-02 Oligopeptider med cycliske, prolin-analoge aminosyrer og farmaceutisk acceptable salte deraf samt deres anvendelse

Country Status (18)

Country Link
US (1) US5206343A (fi)
EP (1) EP0344682B1 (fi)
JP (1) JPH0242098A (fi)
KR (1) KR900000381A (fi)
AT (1) ATE97420T1 (fi)
AU (1) AU624142B2 (fi)
CA (1) CA1331498C (fi)
DE (2) DE3818850A1 (fi)
DK (1) DK270289A (fi)
ES (1) ES2061789T3 (fi)
FI (1) FI93646C (fi)
HU (1) HU204539B (fi)
IE (1) IE62846B1 (fi)
IL (1) IL90482A0 (fi)
NO (1) NO177677C (fi)
NZ (1) NZ229384A (fi)
PT (1) PT90740B (fi)
ZA (1) ZA894178B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8929070D0 (en) * 1989-12-22 1990-02-28 Fujisawa Pharmaceutical Co Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
JPH062347B2 (ja) * 1989-12-29 1994-01-12 東レ株式会社 繊維強化樹脂管状体およびその成形用プリプレグ
FR2746394B1 (fr) 1996-03-20 1998-05-29 Roussel Uclaf Nouveaux composes tricycliques, leur procede de preparation, et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
EP0796855B1 (de) 1996-03-20 2002-02-06 Hoechst Aktiengesellschaft Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19653647A1 (de) 1996-12-20 1998-06-25 Hoechst Ag Vitronectin - Rezeptorantagonisten, deren Herstellung sowie deren Verwendung
DE19741235A1 (de) 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6855510B2 (en) * 2001-03-20 2005-02-15 Dana Farber Cancer Institute, Inc. Pharmaceuticals and methods for treating hypoxia and screening methods therefor
EP1420786A2 (en) * 2001-08-23 2004-05-26 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Methods of inhibiting formation of vascular channels and proliferation using pyridinone derivatives
GB0206711D0 (en) * 2002-03-21 2002-05-01 Isis Innovation HIF Inhibitor
JP2007530522A (ja) * 2004-03-26 2007-11-01 アイシス・イノベーション・リミテッド アッセイ
GB0519605D0 (en) 2005-09-26 2005-11-02 Isis Innovation Assay
KR100600032B1 (ko) * 2006-02-15 2006-07-13 주식회사유라텍 박막형 디스플레이 패널의 산업용 롤러와 그 제조방법
GB201102659D0 (en) 2011-02-15 2011-03-30 Isis Innovation Assay
GB201113101D0 (en) 2011-07-28 2011-09-14 Isis Innovation Assay

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56139455A (en) * 1980-04-02 1981-10-30 Santen Pharmaceut Co Ltd Sulfur-containing acylaminoacid
EP0106341B1 (en) * 1982-10-20 1989-01-11 Takeda Chemical Industries, Ltd. Physiologically active substance p-23924, its production and use
US4833471A (en) * 1984-03-26 1989-05-23 Canon Kabushiki Kaisha Data processing apparatus
IT1176983B (it) * 1984-10-16 1987-08-26 Zambon Spa Dipeptidi ad attivita' farmacologica
EP0190852A3 (en) * 1985-01-31 1988-11-02 Ajinomoto Co., Inc. Dipeptide derivatives and antihypertensive drugs containing them
DE3544338A1 (de) * 1985-12-14 1987-06-19 Hoechst Ag Peptid-derivate mit inhibitorischer wirkung auf hydroxylierende enzyme, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
IT1196485B (it) * 1986-07-14 1988-11-16 Zambon Spa Derivati dell'acido tiazolidin-4-carbossilico ad attivita' farmaceutica
DE3643012A1 (de) * 1986-12-17 1988-06-30 Hoechst Ag 2,3-disubstituierte isoxazolidine, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
IT1223565B (it) * 1987-12-21 1990-09-19 Zambon Spa Derivati dell'acido tiazolidin 4 carbossilico ad attivita' farmaceutica

Also Published As

Publication number Publication date
EP0344682B1 (de) 1993-11-18
ES2061789T3 (es) 1994-12-16
FI892688A (fi) 1989-12-04
PT90740B (pt) 1994-10-31
NZ229384A (en) 1991-12-23
AU3595289A (en) 1989-12-07
FI93646B (fi) 1995-01-31
IL90482A0 (en) 1990-01-18
IE891813L (en) 1989-12-03
DE3818850A1 (de) 1989-12-07
EP0344682A2 (de) 1989-12-06
NO177677C (no) 1995-11-01
IE62846B1 (en) 1995-03-08
US5206343A (en) 1993-04-27
EP0344682A3 (de) 1991-06-26
PT90740A (pt) 1989-12-29
JPH0242098A (ja) 1990-02-13
ZA894178B (en) 1990-02-28
HU204539B (en) 1992-01-28
DE58906191D1 (de) 1993-12-23
AU624142B2 (en) 1992-06-04
FI93646C (fi) 1995-05-10
DK270289D0 (da) 1989-06-02
ATE97420T1 (de) 1993-12-15
KR900000381A (ko) 1990-01-30
NO892265L (no) 1989-12-04
CA1331498C (en) 1994-08-16
FI892688A0 (fi) 1989-06-01
NO177677B (no) 1995-07-24
NO892265D0 (no) 1989-06-02
HUT51294A (en) 1990-04-28

Similar Documents

Publication Publication Date Title
DK270289A (da) Oligopeptider med cycliske, prolin-analoge aminosyrer og farmaceutisk acceptable salte deraf samt deres anvendelse
NO306901B1 (no) Piperazinderivater, anvendelser derav, samt farmasöytiske preparater omfattende slike derivater
FI962753A (fi) Menetelmä lääkeaineena käytt¦kelpoisen piperidyyli- tai pyrrolidiinijohdannaisen tai sen farmaseuttisen suolan valmistamiseksi
ES2075849T3 (es) Derivados heterociclicos.
DK138283D0 (da) Spiro(4.(3+n))-2-aza-3-carboxylsyre-derivater, fremgangsmade til fremstilling deraf samt midler indeholdende disse forbindelser og deres anvendelse
FI904441A0 (fi) Aminosyraderivat med reninhaemmande egenskaper, foerfaranden foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning.
IE873418L (en) 5-oxaproline based peptides
KR880007461A (ko) 헤테로 사이클-치환 디포스포네이트화합물 및 이의 약제학적 조성물
SE8406141L (sv) N-acylaminosyradiamidderivat, salter derav, forfarande for deras framstellning och antiulcermedel innehallande dessa
DK492288D0 (da) Amidforbindelser, farmaceutisk praeparat indeholdende samme samt fremgangsmaade til fremstilling af forbindelserne
NO895123L (no) C63-amidderivater av 34-de(acetylglukosaminyl)-34-deoksyteicoplaniner og fremgangsmaate for deres fremstilling.
ATE104678T1 (de) Renin-hemmende aminodiol-derivate.
ATE84303T1 (de) Cysteinderivate.
DK141187D0 (da) 1-(3-(2-dialkylaminoethoxy)-2-thienyl)-3-phenyl-1-propanoner og syreadditionssalte deraf, fremgangsmaade af saadanne forbindelser samt farmaceutiske praeparater indeholdende disse

Legal Events

Date Code Title Description
ATS Application withdrawn